We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

As pandemic restrictions begin to lift, you may be thinking about travelling. Today, in addition to considering your plans to travel with osteoporosis you must also be clear on travel […]

  BÜBL™ WINS BRONZE LION This year, Osteoporosis Canada launched a transformative campaign intended to disrupt the osteoporosis landscape, while shining a light on a disease that affects 2 million […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

Dr. Rowena Ridout is the new chair of Osteoporosis Canada’s Scientific Advisory Council. Rowena has been involved with Osteoporosis Canada since 2010 as an active member of the Scientific Advisory Council.  […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Managing Pain You may or may not experience pain with a diagnosis of osteoporosis. There are several reasons why an individual with osteoporosis might experience pain: As described above, fractures […]

Yoga has many benefits to mind, body and spirit. But for someone with osteoporosis or at risk of a broken bone, there are some movements that should be modified or […]

A recent report by the US Preventive Services Task Force (USPSTF) suggests that low doses of vitamin D up to 400 IU daily and calcium supplements up to 1000 mg […]